Author

Mary Wimsett

Cincinnati Children's Hospital Medical CenterORCID 0009-0001-4334-2495Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

Anna H. Cox· 1 shared Chunming LiuiD· 1 shared Emma C. Arvin· 1 shared Jessica S. BlackburniD· 1 shared Majd A. Al‐HamalyiD· 1 shared Meghan G. HaneyiD· 1 shared Shilpa Sampathi· 1 shared Wen ZhangiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna H. Cox

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyBiomedicine & PharmacotherapyPeer-reviewedDec 16, 2023

Zebrafish Drug Screening Identifies Erlotinib as an Inhibitor of Wnt/β-Catenin Signaling and Self-Renewal in T-cell Acute Lymphoblastic Leukemia

Majd A. Al‐Hamaly, Anna H. Cox, Meghan G. Haney…·Jessica S. Blackburn

This study identifies Erlotinib as a Wnt/β-catenin inhibitor effective in zebrafish and human cells, reducing leukemia-initiating cell self-renewal and disease progression.

13 citations

zebrafishhuman

𝕏 PostBluesky